CClinicalTrials.gg
RecruitingNCT07100379BITESUpdated Apr 30, 2026

Balloon Inflation Time for Esophageal Strictures (BITES): A Randomized Multi-Center Study

An interventional study of Endoscopic Balloon Dilation in Esophageal Atresia With Tracheo-esophageal Fistula, Esophageal Atresia and Esophageal Strictures, sponsored by Boston Children's Hospital. Recruiting at 2 sites in United States. Open to participants aged Up to 18 Years. Per ClinicalTrials.gov, last updated 2026-04-30.

Sponsored by Boston Children's Hospital · Not applicable, Interventional, and Treatment

Phase
Not applicable
Study type
Interventional
Enrollment
128
Allocation
Randomized
Ages
Up to 18 Years
Sex
All
01

Study summary

Esophageal atresia (EA) is one of the most common gastrointestinal congenital anomalies that affects 1 in 2500 to 1 in 4000 live births. It is characterized by abnormal development of the esophagus, which requires surgical intervention to be compatible with life. Surgical repair of EA is associated with risk of developing esophageal strictures or narrowing, which nearly affects 40% of cases. Strictures can be treated using endoscopic balloon dilation, which consists of introducing a catheter with a balloon into the esophagus via endoscopy and positioning it across stricture followed by balloon inflation. The inflated balloon is held in position for a set amount of time with the goal to dilate the narrowed area. At this time there are no pediatric studies comparing difference balloon dilation times and outcomes. Our study's goal is to evaluate balloon dilation inflation time in treating esophageal anastomotic strictures to understand if inflation time is associated with outcome.

02

Conditions studied

  • Esophageal Atresia With Tracheo-esophageal Fistula
  • Esophageal Atresia
  • Esophageal Strictures

Keywords

  • endoscopic balloon dilation
  • post-surgical correction
  • esophageal strictures
03

Who can participate

Ages eligible
Up to 18 Years
Sexes eligible
All
Accepts healthy volunteers
No

Inclusion criteria

  • Diagnosed with esophageal atresia with and without tracheoesophageal fistula, surgically repaired esophageal atresia, esophageal anastomotic strictures requiring endoscopic balloon dilation, and at least 1 endoscopic balloon dilation for esophageal anastomotic strictures within a 6 month period.

Exclusion criteria

Exclusion Criteria:

  • Patients who need endoscopic incisional therapy to manage anastomotic stricture during their first follow up endoscopy, patients requiring administration of intralesional steroid within 4 weeks of repair, have no follow up endoscopy within 6 months period, have any anastomosis type other than esophago-esophageal (e.g. jejunal or colonic interposition), and/or failure to meet target dilation time.
04

Study design

Phase
Not applicable
Primary purpose
Treatment
Allocation
Randomized
Intervention model
Parallel assignment
Masking
Single (Participant)
Enrollment
128 participants (estimated)

Study arms

  • Experimental
    Group A (30 seconds)

    Patients who are randomized into Group A will undergo endoscopic balloon dilation for a total of 30 seconds.

    Procedure: Endoscopic Balloon Dilation

  • Experimental
    Group B (180 seconds)

    Patients randomized into Group B will undergo endoscopic balloon dilation for a duration of 180 seconds.

    Procedure: Endoscopic Balloon Dilation

Interventions

  • ProcedureEndoscopic Balloon Dilation

    Endoscopic balloon dilation is a routine procedure in which a catheter with a balloon is introduced into the esophagus to help treat esophageal strictures via endoscope. The catheter is placed directly across the span of the esophageal stricture and the balloon is inflated to pre-determined volume in order to dilate the esophageal stricture. Balloon will remain inflated for either 30 or 180 seconds based on patient's randomization.

05

What researchers measure

Primary outcomes

  1. Stricture response to endoscopic balloon dilation

    Study aims to determine whether the efficacy of endoscopic ballon dilation depends on duration of balloon inflation duration and does this influence the need for repeat endoscopic balloon dilations. Response to dilation will be defined by total number of dilations needed to treat stricture in a 6 month period.

    Time frame: 6 months

Secondary outcomes

  1. Change in esophageal anastomotic diameter

    Secondary outcome measures will include esophageal anastomotic diameter at the conclusion of the study period compared to starting esophageal diameter.

    Time frame: 6 months

06

Study locations

2 of 2 sites recruiting
07

References and documents

Publications

  • Khan AA, Shah SW, Alam A, Butt AK, Shafqat F, Castell DO. Pneumatic balloon dilation in achalasia: a prospective comparison of balloon distention time. Am J Gastroenterol. 1998 Jul;93(7):1064-7. doi: 10.1111/j.1572-0241.1998.00330.x. PubMed 9672331 ↗
  • Wallner O, Wallner B. Balloon dilation of benign esophageal rings or strictures: a randomized clinical trial comparing two different inflation times. Dis Esophagus. 2014 Feb-Mar;27(2):109-11. doi: 10.1111/dote.12080. Epub 2013 Apr 26. PubMed 23621385 ↗
  • Ten Kate CA, Tambucci R, Vlot J, Spaander MCW, Gottrand F, Wijnen RMH, Dall'Oglio L. An international survey on anastomotic stricture management after esophageal atresia repair: considerations and advisory statements. Surg Endosc. 2021 Jul;35(7):3653-3661. doi: 10.1007/s00464-020-07844-6. Epub 2020 Aug 3. PubMed 32748272 ↗
  • Kovesi T, Rubin S. Long-term complications of congenital esophageal atresia and/or tracheoesophageal fistula. Chest. 2004 Sep;126(3):915-25. doi: 10.1378/chest.126.3.915. PubMed 15364774 ↗
  • Castilloux J, Noble AJ, Faure C. Risk factors for short- and long-term morbidity in children with esophageal atresia. J Pediatr. 2010 May;156(5):755-60. doi: 10.1016/j.jpeds.2009.11.038. Epub 2010 Jan 31. PubMed 20123142 ↗
  • Serhal L, Gottrand F, Sfeir R, Guimber D, Devos P, Bonnevalle M, Storme L, Turck D, Michaud L. Anastomotic stricture after surgical repair of esophageal atresia: frequency, risk factors, and efficacy of esophageal bougie dilatations. J Pediatr Surg. 2010 Jul;45(7):1459-62. doi: 10.1016/j.jpedsurg.2009.11.002. PubMed 20638524 ↗
  • Krishnan U, Mousa H, Dall'Oglio L, Homaira N, Rosen R, Faure C, Gottrand F. ESPGHAN-NASPGHAN Guidelines for the Evaluation and Treatment of Gastrointestinal and Nutritional Complications in Children With Esophageal Atresia-Tracheoesophageal Fistula. J Pediatr Gastroenterol Nutr. 2016 Nov;63(5):550-570. doi: 10.1097/MPG.0000000000001401. PubMed 27579697 ↗

Individual participant data

Plan to share: No — Individual participant data will not be shared. Individual data will not provide us with an overall understanding of the efficacy of endoscopic ballon dilation, which is the primary goal of our study. This study will focus on analyzing the results obtained from the cohort as a whole and the results obtained from that analysis will be shared as part of a future manuscript.

08

Registry details

Key details

Study ID
NCT07100379
Lead sponsor
Boston Children's Hospital
Collaborators
Children's Hospital of Philadelphia
Responsible party
Jessica Lacy Yasuda (Attending Physician, Boston Children's Hospital) — Principal investigator
First posted
Aug 3, 2025
Start date
Oct 28, 2025
Primary completion
Jun 24, 2027 (estimated)
Completion
Jun 24, 2028 (estimated)
Last update
Apr 30, 2026

Study contacts

Jessica Yasuda, MD
Contact
Jessica.Yasuda@childrens.harvard.edu
617-355-3038
James Orozco, DO
Contact
james.orozco@childrens.harvard.edu
Jessica Yasuda, MD
principal investigator · Boston Children's Hospital

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Interested in this study?

Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.

Contact study team

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion